Company Profiles

Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Analysis

  • CAN656660
  • 25 Pages
  • August 2016
  • Company Profiles
Summary
Canadean's Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, mergers and acquisitions, recent developments, key employees as well as company locations and subsidiaries.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about Grupo Ferrer Internacional, S.A.

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
Grupo Ferrer Internacional, S.A. (Ferrer) is a pharmaceutical company based in Spain. The company manufactures and markets pharmaceutical products for various therapeutic areas such as cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, musculoskeletal system, pain management, pediatrics and the respiratory system. It also offers diagnostics services through its subsidiary Ferrer inCode. Apart from these, Ferrer offers vaccine solutions for allergies, generic drugs and consumer healthcare products such as dermocosmetics, sunscreens, food supplements, infant nutrition products, over-the counter medicines, insect repellants and antilice products. The company also offers fine chemicals, and food and feed ingredients. It operates production facilities across Germany, Mexico and Spain. The company also operates a logistics center in Spain. Ferrer is headquartered in Barcelona, Spain.

- This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

- The SWOT analysis identifies the company's strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

- The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

ReasonsToBuy
- Quickly enhance your understanding of Grupo Ferrer Internacional, S.A.

- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

- Increase business/sales activities by understanding your competitors' businesses better.

- Recognize potential partnerships and suppliers.

Key Highlights
Grupo Ferrer Internacional, S.A. (Ferrer) is a pharmaceutical company based in Spain. The company manufactures and markets pharmaceutical products for various therapeutic areas such as cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, musculoskeletal system, pain management, pediatrics and the respiratory system. It also offers diagnostics services through its subsidiary Ferrer inCode. Apart from these, Ferrer offers vaccine solutions for allergies, generic drugs and consumer healthcare products such as dermocosmetics, sunscreens, food supplements, infant nutrition products, over-the counter medicines, insect repellants and antilice products. The company also offers fine chemicals, and food and feed ingredients. It operates production facilities across Germany, Mexico and Spain. The company also operates a logistics center in Spain. Ferrer is headquartered in Barcelona, Spain.
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

2017 © Copyright Big Market Research

View Pricing >>